CNTX-6016

N/A

Report date: 2023/11/16 17:14:24
NME

Base Information

Drug NameCNTX-6016
Drug Alias NameCNTX-6016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsNociceptive PainChronic PainPain +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesCentrexion Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsDiabetic Neuropathies
Inactive IndicationsNociceptive PainChronic PainPain

Other Information

ATC CodeN/A
Related LinksN/A